ANTX AN2 THERAPEUTICS INC Management Changes 8-K Filing 2023 - Appointment and Departure of Officers AN2 Therapeutics appoints Lucy Day as Principal Accounting Officer and hires Annie Yoshiyama as Vice President, Finance and Corporate Controller.Get access to all SEC 8-K filings of the AN2 THERAPEUTICS INC